Viewing nowIdalbi Tablet 80mg (Azilsartan Medoxomil)
Potassium Azilsartan Medoxomil 85.36mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 202303420 · Approved 2023.12.22 · Insurance code 693903720
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is chronically elevated, placing strain on the heart and blood vessels. This medication helps control blood pressure, reducing the risk of cardiovascular diseases and helping to prevent complications. Therefore, it is used for essential hypertension.
1) Adults The recommended initial dose of this medicine is 40 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, it may be increased to a maximum of 80 milligrams once daily. The blood pressure-lowering effect occurs within 2 weeks after starting treatment, with the maximum effect appearing at approximately 4 weeks. If blood pressure is not controlled with this medicine alone, additional blood pressure-lowering effects may be achieved when it is administered in combination with other antihypertensive agents [diuretics (e.g., chlorthalidone, hydrochlorothiazide) or calcium channel blockers]. 2) Elderly patients No initial dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. For very elderly patients (aged 75 years or older) who are at risk of hypotension, an initial dose of 20 milligrams may be considered. 3) Patients with renal impairment No dose adjustment of this medicine is necessary in patients with mild or moderate renal impairment. Use caution because there is no experience with the use of this medicine in patients with severe renal impairment or end-stage renal disease (ESRD). Azilsartan is not removed by hemodialysis. 4) Patients with hepatic impairment This medicine is not recommended for patients with severe hepatic impairment because it has not been studied in this population. Experience with the use of this medicine in patients with mild to moderate hepatic impairment is limited; therefore, close monitoring is recommended, and an initial dose of 20 milligrams should be considered. 5) Patients with intravascular volume depletion For patients with salt depletion or who may have volume depletion (e.g., patients with vomiting or diarrhea, or those receiving high doses of diuretics), start treatment with this medicine under close medical supervision and consider an initial dose of 20 milligrams.
The safety and efficacy of this medicine in children and adolescents under 18 years of age have not been established.
This medication can cause serious harm or death to the fetus and newborn, especially during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, it must be stopped immediately. Patients with allergies to any components of this medication, pregnant women, diabetics, and those with moderate to severe kidney dysfunction should not take this medication. Patients with heart failure, kidney issues, or renal artery stenosis who rely on the renin-angiotensin-aldosterone system should carefully use this medication, with close monitoring of blood pressure and kidney function. It is not recommended to use this medication in combination with other renin-angiotensin system drugs as this could increase the risk of hypotension, hyperkalemia, and renal impairment. Caution should be exercised in patients with decreased blood volume, such as those experiencing vomiting or diarrhea, or those taking high-dose diuretics as initial hypotension may occur; dosage adjustments should be made under medical supervision if necessary. Due to the risk of hyperkalemia, regularly check serum potassium levels when used with potassium-sparing diuretics, potassium supplements, or potassium-containing salt substitutes. Particular caution is needed for elderly patients or diabetics with impaired renal function. Side effects such as dizziness, headache, hypotension, nausea, and diarrhea may occur during treatment, and if these symptoms worsen, consultation with a healthcare professional is recommended. Caution is necessary when driving or operating machinery as drowsiness or dizziness may occur. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should also avoid this medication. Overdosage can lead to hypotension and dizziness; if these symptoms occur, notify a healthcare professional immediately for appropriate intervention. This medication should be stored away from direct sunlight and moisture, kept in its original packaging, and kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that protects it from light and air and is best kept at room temperature between 1 degree and 30 degrees Celsius. Additionally, to maintain its efficacy, it should be kept in a dry area, avoiding places with high humidity.
White or almost white round tablet
PTP packaging - 28 tablets/Alu-Alu[(14 X 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPotassium Azilsartan Medoxomil 85.36mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Potassium Azilsartan Medoxomil 21.34mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Potassium Azilsartan Medoxomil 85.36mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Potassium Azilsartan Medoxomil 42.68mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Potassium Azilsartan Medoxomil 42.68mg
Tablet · Prescription medication
Celltrion Healthcare Co., Ltd.

Potassium Azilsartan Medoxomil 21.34mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.